
    
      OBJECTIVES:

        -  To determine the safety and efficacy of antiepileptic drug monotherapy comprising
           levetiracetam or pregabalin in treating seizures in patients undergoing chemotherapy
           and/or radiotherapy for primary brain tumors.

      OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.

        -  Arm I: Patients receive levetiracetam.

        -  Arm II: Patients receive pregabalin. Patients are followed at 2 weeks, 2 months, 6
           months, and then at 1 year.
    
  